Unlock instant, AI-driven research and patent intelligence for your innovation.

Kainate-binding human CNS receptors of the EAA4 family

a human cns receptor and kainate technology, applied in the field of kainate-binding human cns receptors of the eaa4, can solve the problems of limited availability of brain tissue of human origin, difficult development of therapeutics which modulate these processes, and complicated search for human therapeutics

Inactive Publication Date: 2002-11-14
NPS ALLELIX CORP
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

This approach provides a reliable and homogeneous system for screening candidate compounds interacting with human EAA receptors, overcoming the limitations of heterogeneous receptor sources and enabling the assessment of ligand binding and ion channel activation, thus facilitating the development of therapeutics for CNS disorders.

Problems solved by technology

However, the development of therapeutics which modulate these processes has been very difficult, due to the lack of any homogeneous source of receptor material with which to discover selectively binding drug molecules, which interact specifically at the interface of the EAA receptor.
The search for human therapeutics is further complicated by the limited availability of brain tissue of human origin.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Kainate-binding human CNS receptors of the EAA4 family
  • Kainate-binding human CNS receptors of the EAA4 family
  • Kainate-binding human CNS receptors of the EAA4 family

Examples

Experimental program
Comparison scheme
Effect test

example 1

Isolation of DNA Coding for the Human EAA4a Receptor

[0050] cDNA coding for the human EAA4a receptor was identified by probing human fetal brain cDNA that was obtained as an EcoRI-based lambda phage library (lambda ZAP) from Stratagene Cloning Systems (La Jolla, Calif., U.S.A.). The cDNA library was screened using an oligonucleotide probe capable of annealing to the 3' region of the rat GluR5 receptor sequence reported by Bettler et al., supra. The specific sequence of the .sup.32P-labelled probe (SEQ ID NO: 9) is provided below:

[0051] 5'-ATCGGCGGCATCTTCATTGTTCTGGCTGCAGGACTCGTGC-3'

[0052] The fetal brain cDNA library was screened under the following hybridization conditions; 6.times. SSC, 25% formamide, 5% Denhardt's solution, 0.5% SOS, 100 ug / ml denatured salmon sperm DNA, 42C. Filters were washed with 2.times. SSC containing 0.5% SDS at 25C. for 5 minutes, followed by a 15 minute wash at 50C. with 2.times. SSC containing 0.5% SDS. The final wash was with 1.times. SSC containing 0.5%...

example 2

Construction of Genetically Engineered Cells Producing the Human EAA4a Receptor

[0054] For transient expression in mammalian cells, cDNA coding for the human EAA4a receptor was incorporated into the mammalian expression vector pcDNA1, which is available commercially from Invitrogen Corporation (San Diego, Calif., USA; catalogue number V490-20). This is a multifunctional 4.2 kb plasmid vector designed for cDNA expression in eukaryotic systems, and cDNA analysis in prokaryotes. Incorporated on the vector are the CMV promoter and enhancer, splice segment and polyadenylation signal, an SV40 and Polyoma virus origin of replication, and M13 origin to rescue single strand DNA for sequencing and mutagenesis, Sp6 and T7 RNA promoters for the production of sense and anti-sense RNA transcripts and a Col E1-like high copy plasmid origin. A polylinker is located appropriately downstream of the CMV promoter (and 3' of the T7 promoter).

[0055] The strategy depicted in FIG. 2 was employed to facilita...

example 3

Ligand Binding Assays

[0059] Transfected cells in the frozen state were resuspended in ice-cold distilled water using a hand homogenizer and centrifuged for 20 minutes at 50,000 g. The supernatant was discarded and the membrane pellet stored frozen at -70.degree. C.

[0060] COS cell membrane pellets were suspended in ice cold 50 mM Tris-HCl (pH 7.55, 5.degree. C.) and centrifuged again at 50,000 g for 10 minutes in order to remove endogenous glutamate that would compete for binding. Pellets were resuspended in ice cold 50 mM Tris-HCl (pH 7.55) buffer and the resultant membrane preparation was used as tissue source for binding experiments described below. Proteins were determined using the Pierce Reagent with BSA as standard.

[0061] Binding assays were then performed, using an amount of COS-derived membrane equivalent to 25-100 ug as judged by protein determination and selected radiolabelled ligand. In particular, for kainate binding assays, incubation mixtures consisted of 25-100 pg tis...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
pHaaaaaaaaaa
pHaaaaaaaaaa
volumeaaaaaaaaaa
Login to View More

Abstract

Neurotransmission by excitatory amino acids (EAAs) such as glutamate is mediated via membrane-bound surface receptors. DNA coding for one family of these receptors of the kainate-binding type of EAA receptors, has now been isolated and the receptor protein characterized. Herein described are recombinant cell lines which produce the EAA receptor as a heterologous membrane-bound product. Also described are related aspects of the invention, which are of commercial significance. Included is use of the cell lines as a tool for discovery of compounds which modulate EAA receptor stimulation.

Description

CROSS-REFERENCE TO RELATED PATENT APPLICATIONS[0001] This application is a divisional of U.S. application Ser. No. 08 / 249,241, filed May 25, 1994, which is a divisional application of U.S. application Ser. No. 07 / 903,456, filed Jun. 24, 1992, incorporated herein by reference in its entirety.[0002] This invention is concerned with applications of recombinant DNA technology in the field of neurobiology. More particularly, the invention relates to the cloning and expression of DNA coding for excitatory amino acid (EAA) receptors, especially human EAA receptors.BACKGROUND [TO] OF THE INVENTION[0003] In the mammalian central nervous system (CNS), the transmission of nerve impulses is controlled by the interaction between a neurotransmitter substance released by the "sending" neuron which then binds to a surface receptor on the "receiving" neuron, to cause excitation thereof. L-glutamate is the most abundant neurotransmitter in the CNS, and mediates the major excitatory pathway in vertebr...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(United States)
IPC IPC(8): C07K14/00C07K14/705C12N5/10C12N15/09C12N15/12C12P21/02C12P21/08C12R1/91G01N33/53
CPCC07K14/70571
Inventor KAMBOJ, RAJENDERELLIOTT, CANDACE E.NUTT, STEPHEN L.
Owner NPS ALLELIX CORP